159 related articles for article (PubMed ID: 16111772)
1. HLA-DRB5*0101 and -DRB1*1501 expression in the multiple sclerosis-associated HLA-DR15 haplotype.
Prat E; Tomaru U; Sabater L; Park DM; Granger R; Kruse N; Ohayon JM; Bettinotti MP; Martin R
J Neuroimmunol; 2005 Oct; 167(1-2):108-19. PubMed ID: 16111772
[TBL] [Abstract][Full Text] [Related]
2. HLA-DQB1*0602 determines disease susceptibility in a new "humanized" multiple sclerosis model in HLA-DR15 (DRB1*1501;DQB1*0602) transgenic mice.
Kaushansky N; Altmann DM; Ascough S; David CS; Lassmann H; Ben-Nun A
J Immunol; 2009 Sep; 183(5):3531-41. PubMed ID: 19648275
[TBL] [Abstract][Full Text] [Related]
3. T cell response to myelin basic protein in the context of the multiple sclerosis-associated HLA-DR15 haplotype: peptide binding, immunodominance and effector functions of T cells.
Vergelli M; Kalbus M; Rojo SC; Hemmer B; Kalbacher H; Tranquill L; Beck H; McFarland HF; De Mars R; Long EO; Martin R
J Neuroimmunol; 1997 Aug; 77(2):195-203. PubMed ID: 9258250
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for the binding of an immunodominant peptide from myelin basic protein in different registers by two HLA-DR2 proteins.
Li Y; Li H; Martin R; Mariuzza RA
J Mol Biol; 2000 Nov; 304(2):177-88. PubMed ID: 11080454
[TBL] [Abstract][Full Text] [Related]
5. Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides.
Vogt AB; Kropshofer H; Kalbacher H; Kalbus M; Rammensee HG; Coligan JE; Martin R
J Immunol; 1994 Aug; 153(4):1665-73. PubMed ID: 7519208
[TBL] [Abstract][Full Text] [Related]
6. No evidence for an effect of DNA methylation on multiple sclerosis severity at HLA-DRB1*15 or HLA-DRB5.
Handel AE; De Luca GC; Morahan J; Handunnetthi L; Sadovnick AD; Ebers GC; Ramagopalan SV
J Neuroimmunol; 2010 Jun; 223(1-2):120-3. PubMed ID: 20394989
[TBL] [Abstract][Full Text] [Related]
7. HLA-DR15 haplotype and multiple sclerosis: a HuGE review.
Schmidt H; Williamson D; Ashley-Koch A
Am J Epidemiol; 2007 May; 165(10):1097-109. PubMed ID: 17329717
[TBL] [Abstract][Full Text] [Related]
8. A NOTCH4 association with multiple sclerosis is secondary to HLA-DR*1501.
Duvefelt K; Anderson M; Fogdell-Hahn A; Hillert J
Tissue Antigens; 2004 Jan; 63(1):13-20. PubMed ID: 14651518
[TBL] [Abstract][Full Text] [Related]
9. Low frequency of the disease-associated DRB1*15-DQB1*06 haplotype may contribute to the low prevalence of multiple sclerosis in Sami.
Harbo HF; Utsi E; Lorentzen AR; Kampman MT; Celius EG; Myhr KM; Lie BA; Mellgren SI; Thorsby E
Tissue Antigens; 2007 Apr; 69(4):299-304. PubMed ID: 17389012
[TBL] [Abstract][Full Text] [Related]
10. The HLA-DR2 haplotype is associated with an increased proliferative response to the immunodominant CD4(+) T-cell epitope in human interferon-beta.
Stickler M; Valdes AM; Gebel W; Razo OJ; Faravashi N; Chin R; Rochanayon N; Harding FA
Genes Immun; 2004 Jan; 5(1):1-7. PubMed ID: 14735143
[TBL] [Abstract][Full Text] [Related]
11. Association of HLA-DR, -DQ, and vitamin D receptor alleles and haplotypes with tuberculosis in the Venda of South Africa.
Lombard Z; Dalton DL; Venter PA; Williams RC; Bornman L
Hum Immunol; 2006 Aug; 67(8):643-54. PubMed ID: 16916662
[TBL] [Abstract][Full Text] [Related]
12. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.
Zivadinov R; Uxa L; Bratina A; Bosco A; Srinivasaraghavan B; Minagar A; Ukmar M; Benedetto Sy; Zorzon M
Int Rev Neurobiol; 2007; 79():521-35. PubMed ID: 17531857
[TBL] [Abstract][Full Text] [Related]
13. Specific overexpression of rheumatoid arthritis-associated HLA-DR alleles and presentation of low-affinity peptides.
Kerlan-Candon S; Louis-Plence P; Wiedemann A; Combe B; Clot J; Eliaou JF; Pinet V
Arthritis Rheum; 2001 Jun; 44(6):1281-92. PubMed ID: 11407687
[TBL] [Abstract][Full Text] [Related]
14. Human leukocyte antigen class II allele association to disease progression in Iranian patients with chronic lymphocytic leukemia.
Hojjat-Farsangi M; Jeddi-Tehrani M; Amirzargar AA; Razavi SM; Sharifian RA; Rabbani H; Shokri F
Hum Immunol; 2008 Oct; 69(10):666-74. PubMed ID: 18722491
[TBL] [Abstract][Full Text] [Related]
15. Multiple sclerosis.
Compston A; Kellar-Wood H; Wood N
Baillieres Clin Neurol; 1994 Aug; 3(2):353-71. PubMed ID: 7952852
[TBL] [Abstract][Full Text] [Related]
16. HLA-DR15 is associated with lower age at onset in multiple sclerosis.
Masterman T; Ligers A; Olsson T; Andersson M; Olerup O; Hillert J
Ann Neurol; 2000 Aug; 48(2):211-9. PubMed ID: 10939572
[TBL] [Abstract][Full Text] [Related]
17. Human Leukocyte Antigen (HLA)-DRB1*15:01 and HLA-DRB5*01:01 Present Complementary Peptide Repertoires.
Scholz EM; Marcilla M; Daura X; Arribas-Layton D; James EA; Alvarez I
Front Immunol; 2017; 8():984. PubMed ID: 28871256
[TBL] [Abstract][Full Text] [Related]
18. Additive effect of the HLA-DR15 haplotype on susceptibility to multiple sclerosis.
Rasmussen HB; Kelly MA; Clausen J
Mult Scler; 2001 Apr; 7(2):91-3. PubMed ID: 11424637
[TBL] [Abstract][Full Text] [Related]
19. Parent-of-origin of HLA-DRB1*1501 and age of onset of multiple sclerosis.
Ramagopalan SV; Byrnes JK; Dyment DA; Guimond C; Handunnetthi L; Disanto G; Yee IM; Ebers GC; Sadovnick AD
J Hum Genet; 2009 Sep; 54(9):547-9. PubMed ID: 19629136
[TBL] [Abstract][Full Text] [Related]
20. HLA Dr-Dq haplotypes and the TNFA-308 polymorphism: associations with asthma and allergy.
Munthe-Kaas MC; Carlsen KL; Carlsen KH; Egeland T; Håland G; Devulapalli CS; Akselsen H; Undlien D
Allergy; 2007 Sep; 62(9):991-8. PubMed ID: 17686102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
